InvestorsHub Logo
Followers 19
Posts 1611
Boards Moderated 0
Alias Born 03/21/2017

Re: sello post# 26354

Wednesday, 04/18/2018 9:49:17 PM

Wednesday, April 18, 2018 9:49:17 PM

Post# of 33238
So I am going to share some information with you guy's despite my general distaste for these boards as of late (too many personal attacks and negative posts all the time).

They already have positive clinical data in chronic kidney disease patients (a small 4 patient feasibility trial) that sought to evaluate the potential ability of PEMF to reduce proteinuria in CKD as well as to look at potential synergies with angiotensin receptor blockers.

This small study was conducted in 2010 and the abstract was presented at the National Kidney Foundation's 2010 Spring Clinical Meetings.

Here is a link to the PDF with all of the abstracts (look at page 158): National Kidney Foundation 2010 Spring Clinical Meetings Abstracts Book

Look up proteinuria and see why this could be big and why I have been saying that CKD is probably the big indications as they could partner with DaVita or Fresenius and then be bought out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENDV News